National Research Corporation

National Research Corporation

NRCยทNASDAQ

$19.59

-2.8%
HealthcareMedical - Healthcare Information Services

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

At a Glance

Live Snapshot
Market Cap$441.49M
EPS0.5200
P/E Ratio36.22
Earnings Date07/27/2026

Intrinsic Alpha Methodology

Thesis Lenses

Signal ยท Driver ยท Risk

Signal

High confidence

Valuation multiple is elevated (P/E 36.2).

Valuation inputs: P/E 36.2, earnings yield +2.8%, momentum -2.8%.

If multiples stay elevated while momentum fades, downside repricing risk rises.

Driver

High confidence

Return profile is strong (ROE +82.9%, ROIC +14.4%).

Profitability stack: net margin +8.4%, ROE +82.9%, ROIC +14.4%.

Quality deterioration often appears in margins before it shows up in headline EPS.

Risk

High confidence

Downside profile is elevated and scenario stress-testing is essential.

Risk factors: liabilities/assets +89.6%, momentum -2.8%, net margin +8.4%.

Higher leverage with weak momentum and thin margins can amplify drawdown severity.

nrc

National Research Corporation Market vs Earnings Trajectory

NRC ยท NASDAQ

Loading price and EPS data...

National Research Corporation

National Research Corporation Fair Value Envelope

NRC ยท NASDAQ

Our analysis suggests that NRC has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $19.59, this represents a potential HIDDEN relative to our calculated worth for National Research Corporation.

Intrinsic Value
Current Price: $19.59
3Y-59.0%
5Y-65.0%
10Y+6.0%
3Y-9.0%
5Y+3.0%
10Y+26.0%
3Y-64.0%
5Y-69.0%
10Y-43.0%
3Y-27.0%
5Y-35.0%
10Y-1.0%
3Y-40.0%
5Y-57.0%
10Y-31.0%
3Y+3.0%
5Y+1.0%
10Y+12.0%
National Research Corporation

National Research Corporation Profit Bridge

NRC ยท NASDAQ
Revenue137.39M
Cost of Goods Sold (59.99M)
Gross Profit77.39M
Operating Expenses (54.80M)
Operating Income22.59M
Interest Expense (4.76M)
Other Income/Expense-4.75M
Pretax Income17.84M
Income Tax (6.24M)
Net Income11.60M
Net Income
11.60M

Profitability Analysis

Gross Margin

56.3%

Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.

Operating Margin

16.4%

Healthy operating margins demonstrate effective cost control and strong business fundamentals.

Net Profit Margin

8.4%

Moderate profitability with room for improvement. Monitor interest expenses and tax efficiency.

Effective Tax Rate

35.0%

Higher tax burden may reflect limited tax optimization or operations in high-tax jurisdictions.

Profitability Insight

High margin compression: Large gap between gross and net margins suggests operational inefficiencies or heavy debt burden. Focus on expense management and deleveraging.

56.33%
Gross Profit Margin
-6%
3Y-10.0%
5Y-11.0%
10Y-3.0%
16.44%
Operating Profit Margin
-33%
3Y-46.0%
5Y-49.0%
10Y-42.0%
8.44%
Net Profit Margin
-51%
3Y-60.0%
5Y-70.0%
10Y-55.0%
82.92%
Return on Equity
5%
3Y+88.0%
5Y+43.0%
10Y+235.0%
8.60%
Return on Assets
-54%
3Y-65.0%
5Y-69.0%
10Y-49.0%
14.36%
Return on Invested Capital
-45%
3Y-57.0%
5Y-60.0%
10Y-35.0%
NRC

National Research Corporation Cash Conversion Engine

NRC ยท NASDAQ
Net Income11.60M
Depreciation & Amortization7.62M
Stock-Based Compensation3.31M
Change in Working Capital916.00K
Others545.00K
Capital Expenditures-10.71M
Free Cash Flow15.74M

Cash Flow Quality Analysis

FCF Conversion Rate

135.7%

Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.

CapEx Intensity

40.5%

Capital-intensive operations require significant reinvestment. Monitor whether CapEx is maintenance or growth-oriented.

FCF Growth Trend

-17.9%

Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.

Working Capital Impact

+$916.00K

Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.

Cash Flow Quality Insight

Solid cash generation: Positive free cash flow with reasonable earnings quality provides financial flexibility for growth investments, debt reduction, or shareholder returns.

nrc

National Research Corporation Funding & Solvency Profile

NRC ยท NASDAQ
Cash & Cash Equivalents2.55M
Net Receivables10.83M
Inventory0.00
Other Current Assets6.60M
Total Current Assets20 M
Property, Plant & Equipment40.30M
Goodwill & Intangible Assets66.15M
Long-Term Investments0.00
Other Non-Current Assets8.12M
Total Non-Current Assets48 M
Total Assets
134.56M

Financial Health Analysis

Current Ratio

0.52x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Debt-to-Equity Ratio

8.97x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

-18486000

Negative working capital indicates short-term liabilities exceed short-term assetsโ€”potential liquidity stress.

Asset Composition

15% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Financial stress indicators: Both liquidity and leverage metrics raise concerns. The company may face challenges meeting obligations and should focus on strengthening its balance sheet.

nrc

National Research Corporation Street Expectations Map

NRC ยท NASDAQ

No Target Data

No analyst price targets available for nrc.

nrc

National Research Corporation Insider Positioning

NRC ยท NASDAQ

During the last 12 months, insiders have purchased $896K worth of NRC shares, with no selling activity reported.

3 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

3-6 Months

Bought

8.0K

98.16K

Sold

0

0.00

Net Activity

+98K

+$98K

6-9 Months

Bought

67.9K

788.03K

Sold

0

0.00

Net Activity

+788K

+$788K

9-12 Months

Bought

771

10.00K

Sold

0

0.00

Net Activity

+10K

+$10K

Top Buyers

1
WPA

Wheeler Penny Ann

Director

22.6K sharesโ€ข1 transactions

$263K

2
BDM

Berwick Donald M

Director

22.6K sharesโ€ข1 transactions

$263K

3
NJN

Nunnelly John N

Director

22.6K sharesโ€ข1 transactions

$263K

4
HSR

Harrison Shane R

Officer: Evp & Chief Financial Officer

8.0K sharesโ€ข1 transactions

$98K

5
FJN

Freeman Jordan Nicole

Officer: Chief Accounting Officer

771 sharesโ€ข1 transactions

$10K

Top Sellers

No selling activity

Insider Activity Analysis

Net Insider Sentiment

Bullish

Strong bullish signal with $896K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.

Buy/Sell Ratio

โˆž:1

Perfect buy/sell ratio. Only buying activity with zero sellingโ€”the most bullish possible insider signal.

Insider Participation

High Buying

5 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.

Insider Activity Insight

Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.

0.98%
Dividend Yield
48%
3Y+258.0%
5Y-
10Y-4.0%
ย 

nrc Dividend History

NRC
10Y CAGR 10%
Latest $0.16
Annual $0.72
Stable dividend payments
Last Period: +0%